| scholarly article | Q13442814 |
| P356 | DOI | 10.1192/BJP.180.5.434 |
| P698 | PubMed publication ID | 11983641 |
| P50 | author | Klaus P. Ebmeier | Q42370256 |
| Michael F Glabus | Q113645500 | ||
| Guy M. Goodwin | Q5622285 | ||
| P2093 | author name string | Shah PJ | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | striatum | Q1319792 |
| treatment-resistant depression | Q7836891 | ||
| P304 | page(s) | 434-440 | |
| P577 | publication date | 2002-05-01 | |
| P1433 | published in | British Journal of Psychiatry | Q4035428 |
| P1476 | title | Chronic, treatment-resistant depression and right fronto-striatal atrophy | |
| P478 | volume | 180 |
| Q30458779 | A cry in the dark: depressed mothers show reduced neural activation to their own infant's cry |
| Q36745469 | A face a mother could love: depression-related maternal neural responses to infant emotion faces |
| Q33397741 | A meta-analysis examining clinical predictors of hippocampal volume in patients with major depressive disorder. |
| Q35000284 | A selective role for ARMS/Kidins220 scaffold protein in spatial memory and trophic support of entorhinal and frontal cortical neurons |
| Q47703956 | Abnormal baseline brain activity in Alzheimer's disease patients with depression: a resting-state functional magnetic resonance imaging study |
| Q48109627 | Abnormal regional spontaneous neural activity in treatment-refractory depression revealed by resting-state fMRI. |
| Q47802190 | Amygdala and regional volumes in treatment-resistant versus nontreatment-resistant depression patients |
| Q33663230 | Antidepressant effects of resveratrol in an animal model of depression |
| Q37060250 | Brain imaging predictors and the international study to predict optimized treatment for depression: study protocol for a randomized controlled trial |
| Q35692258 | Can depression, anxiety and somatization be understood as appeasement displays? |
| Q34345460 | Classification of different therapeutic responses of major depressive disorder with multivariate pattern analysis method based on structural MR scans |
| Q33754464 | Clinical translation of neuroimaging research in mood disorders. |
| Q35236749 | Current perspectives in the management of treatment-resistant depression. |
| Q34153354 | Deep brain stimulation for treatment-resistant depression |
| Q34109804 | Diagnostic and therapeutic utility of neuroimaging in depression: an overview |
| Q38870882 | Episodic memory in depression: the unique contribution of the anterior caudate and hippocampus |
| Q30577346 | Feasibility of studying brain morphology in major depressive disorder with structural magnetic resonance imaging and clinical data from the electronic medical record: a pilot study |
| Q30927398 | In pursuit of neuroimaging biomarkers to guide treatment selection in major depressive disorder: a review of the literature |
| Q35111565 | Is treatment-resistant depression a unique subtype of depression? |
| Q44207595 | Longitudinal MR study of brain structure and hippocampus volume in major depressive disorder |
| Q34100332 | MRI studies in late-life mood disorders |
| Q36464840 | Mass spectrometric quantification of MIF-1 in mouse brain by multiple reaction monitoring |
| Q37978196 | New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates--Nrf2 activators and GSK-3 inhibitors. |
| Q34084297 | Orbitofrontal volume reductions during emotion recognition in patients with major depression |
| Q89071823 | Pathways to Neuroprediction: Opportunities and challenges to prediction of treatment response in depression |
| Q30650490 | Quest for biomarkers of treatment-resistant depression: shifting the paradigm toward risk |
| Q36368849 | Recent developments and current controversies in depression |
| Q41646482 | Reduced GABA neuron density in auditory cerebral cortex of subjects with major depressive disorder. |
| Q35951433 | Relationship between G1287A of the NET Gene Polymorphisms and Brain Volume in Major Depressive Disorder: A Voxel-Based MRI Study |
| Q38290421 | Relevance of the anti-inflammatory properties of curcumin in neurodegenerative diseases and depression. |
| Q34428541 | Resting-state functional connectivity bias of middle temporal gyrus and caudate with altered gray matter volume in major depression |
| Q37058630 | Right external globus pallidus changes are associated with altered causal awareness in youth with depression. |
| Q50775052 | Stress, anxiety, depression, and epilepsy: investigating the relationship between psychological factors and seizures. |
| Q35226749 | Striatal Hypodensities, Not White Matter Hypodensities on CT, Are Associated with Late-Onset Depression in Alzheimer's Disease |
| Q35694665 | Structural MRI-Based Predictions in Patients with Treatment-Refractory Depression (TRD). |
| Q93042725 | Structural brain characteristics in treatment-resistant depression: review of magnetic resonance imaging studies |
| Q34432560 | Temporal-lobe morphology differs between healthy adolescents and those with early-onset of depression |
| Q36870201 | The cognitive neuropsychology of depression in the elderly |
| Q43888085 | The lack of association between components of metabolic syndrome and treatment resistance in depression |
| Q30576881 | The role of BDNF, NTRK2 gene and their interaction in development of treatment-resistant depression: data from multicenter, prospective, longitudinal clinic practice |
| Q41894543 | The role of hippocampal atrophy in depression: a neurocomputational approach |
| Q34267093 | Three-dimensional surface mapping of the caudate nucleus in late-life depression |
| Q48853369 | Unilateral right anterior capsulotomy for refractory major depression with comorbid obsessive-compulsive disorder. |
| Q31033402 | Volumetric brain imaging studies in the elderly with mood disorders |
Search more.